Policy & Compounding
FDA Sent a Compounding Pharmacy a Warning Letter. Here's What It Says.
FDA's September 2026 warning letter has two separate sets of findings. See which one affects patients and which is a legal dispute.
Category
Compounding pharmacies
18 stories tagged compounding pharmacies. Browse all of Policy & Compounding
Policy & Compounding
Why Isn't My Pharmacy Licensed in My State? What to Check
Your vial says one company but your provider lists another pharmacy. See why, what an outsourcing facility is, and how to check your state license.
Medications
Why Your GLP-1 Might Feel Like It’s Not Working: What the Research Says
GLP-1 patients say their medication can feels weaker. Research points to body adaptation, sleep, stress, and hormonal shifts as the usual culprits.
Cost & Coverage
Compounded GLP-1 Pharmacy Additive Search: What to Know
Search compounded GLP-1 pharmacy additives by state. Filter 503A or 503B, compare ingredients, and find a telehealth that works with your pharmacy.
Cost & Coverage
Are Compounded GLP-1s Going Away? Where Things Stand Now (Updated Sept 2026)
A court backed the FDA in August and a warning letter followed in September. See what still allows compounded GLP-1s and what does not.
Editorial review
Sabina
SabinaHonest Belle Health Review: Cost & Experience
Sabina shares her real Belle Health experience, from signup and pricing to shipping speed and level of care. See pros, tradeoffs, and what to know.
Editorial reviewSabina
SabinaMy Review of Fridays: Extra Features, Fast Scheduling, and Tradeoffs to Know
Sabina shares her real experience using Fridays Telehealth, from signup and provider visits to shipping, additives, and what stood out.
Policy & Compounding
New Compounding Laws Could Affect GLP-1 Access in 2026
Proposed state and federal compounding laws could affect GLP-1 access in 2026. Here’s what’s changing and why it matters.
Policy & Compounding
503A vs 503B Pharmacies: A Plain Guide, Updated for 2026
Updated for 2026. How 503A and 503B pharmacies differ, why a 503B may have no state license, the pending FDA change, and how to verify yours.
Medications
What Is a Compounding Pharmacy — and Why It Matters for GLP-1s
Learn how compounding pharmacies work, why FDA oversight matters for GLP-1 safety, and what to check at local or telehealth pharmacies.
Medications
FDA: Compounded GLP‑1 Drugs Show Similar Adverse Events as Name‑Brand Medications
FDA: “many of the adverse events reported for compounded versions appear to be consistent with adverse events for the FDA‑approved products.”
Medications
Compound Changes - The Era of Customized Compounded Medication
It's the end of the shortage style compounding with essential copies. Now compounding requires a medical justification.
Medications
Tirzepatide Changes - We’re actively updating for compounded compliance changes
We're working hard to keep things updated but give us some grace as providers potentially change their offerings around tirzepatide.
Medications
What is a shortage?
We’ve all been hearing about the shortage of tirzepatide or semaglutide, but what is a shortage? How does it impact compounding?
Medications
FDA: Tirzepatide Shortage is over, again!
The FDA has ended the shortage for tirzepatide, essential copy compounding ends on Feb 18 and March 19
Medications
FDA Warns Against Unapproved GLP-1 Drugs for Weight Loss
The FDA warned about counterfeit Ozempic, research peptides, and retatrutide. Medications should be prescribed and filled by state-licensed pharmacies
Policy & Compounding
Nov 21 Update on Compounded Tirzepatide Availability and Ongoing FDA Reevaluation
November 21 joint status report on the OFA vs FDA lawsuit over compounded tirzepatide availability and the FDA's ongoing reevaluation.
Medications
State of Compounding: Summer '24
We put together some data on prices for compounding. Most of the data is from self reported prices from over 6,000 people we’ve polled.